|
Sign In to gain access to subscriptions and/or personal tools.
|
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity
M Cutolo
Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genova, Italy, mcutolo{at}unige.it
A Sulli
Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genova, Italy
S Capellino
Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genova, Italy
B Villaggio
Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genova, Italy
P Montagna
Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genova, Italy
B Seriolo
Research Laboratory and Division of Rheumatology, Department of Internal Medicine, University of Genova, Italy
R H Straub
Laboratory of Neuroendocrinoimmunology, University Hospital of Regensburg, Regensburg, Germany
Sex hormones seem to play an important role as modulators of the autoimmune disease onset/perpetuation. Generally, steroid hormones are implicated in the immune response, with estrogens as enhancers at least of the humoral immunity and androgens and progesterone (and glucocorticoids) as natural immunosuppressors. Synovial fluid levels (SF) of proinflammatory estrogens relative to androgens are significantly elevated in both male and female rheumatoid arthritis (RA) patients, as compared to controls, which is most probably due to increase of local enzymatic aromatase activity. Serum levels of estrogens have been found altered in RA patients, particularly estradiol in man. Thus, available steroid prehormones are rapidly converted to proinflammatory estrogens in the synovial tissue in the presence of inflammatory cytokines (i.e., TNFa, IL-1, IL-6). The increased estrogen concentrations observed in RA SF of both sexes are characterized mainly by the hydroxylated forms, in particular, 16a-hydroxyestrone, showing a mitogenic tumor growth stimulating role. Altered serum hydroxylated estrogens have been found also in serum of systemic lupus erythematosus (SLE) patients. As a matter of fact, our recent studies indicate that 17-b estradiol (E2) clearly enhanced the expression of markers of cell growth and proliferation, whereas testosterone (T) induced an increase of markers indicating DNA damage and apoptosis. In particular, our data further shows that the enhancing role of estrogens on immune/inflammatory response is exerted by activating the NFkB complex pathway. In conclusion, locally increased estrogens (i.e., synovial tissue in RA or skin in SLE) might exert activating effects on cell proliferation, including macrophages and fibroblasts, suggesting new roles for estrogens in autoimmunity.
Key Words: autoimmunity • cytokines • immune system • rheumatic diseases • sex hormones
Lupus, Vol. 13, No. 9,
635-638 (2004)
DOI: 10.1191/0961203304lu1094oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
R. Zivadinov, B. Weinstock-Guttman, K. Hashmi, N. Abdelrahman, M. Stosic, M. Dwyer, S. Hussein, J. Durfee, and M. Ramanathan
Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis
Neurology,
August 18, 2009;
73(7):
504 - 510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O Ichii, A Konno, N Sasaki, D Endoh, Y Hashimoto, and Y Kon
Onset of autoimmune glomerulonephritis derived from the telomeric region of MRL-chromosome 1 is associated with the male sex hormone in mice
Lupus,
May 1, 2009;
18(6):
491 - 500.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Basaria
Androgen Deprivation Therapy, Insulin Resistance, and Cardiovascular Mortality: An Inconvenient Truth
J Androl,
September 1, 2008;
29(5):
534 - 539.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Shahani, M. Braga-Basaria, and S. Basaria
Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis
J. Clin. Endocrinol. Metab.,
June 1, 2008;
93(6):
2042 - 2049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Costa and D. Colia
Treating infertility in autoimmune patients
Rheumatology,
June 1, 2008;
47(suppl_3):
iii38 - iii41.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Flouris, G. S. Metsios, A. Z. Jamurtas, and Y. Koutedakis
Sexual dimorphism in the acute effects of secondhand smoke on thyroid hormone secretion, inflammatory markers and vascular function
Am J Physiol Endocrinol Metab,
February 1, 2008;
294(2):
E456 - E462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tincani, M. Nuzzo, A. Lojacono, M. Cattalini, and A. Meini
Review: Contraception in adolescents with systemic lupus erythematosus
Lupus,
August 1, 2007;
16(8):
600 - 605.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Hirano, D. Furutama, and T. Hanafusa
Physiologically high concentrations of 17beta-estradiol enhance NF-{kappa}B activity in human T cells
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2007;
292(4):
R1465 - R1471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Butts, S. A. Shukair, K. M. Duncan, E. Bowers, C. Horn, E. Belyavskaya, L. Tonelli, and E. M. Sternberg
Progesterone inhibits mature rat dendritic cells in a receptor-mediated fashion
Int. Immunol.,
March 1, 2007;
19(3):
287 - 296.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K H Costenbader and E W Karlson
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Lupus,
November 1, 2006;
15(11):
737 - 745.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. I. Spratt, J. R. Morton, R. S. Kramer, S. W. Mayo, C. Longcope, and C. P. H. Vary
Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization
Am J Physiol Endocrinol Metab,
September 1, 2006;
291(3):
E631 - E638.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tirosh, D. Mandel, F. B. Mimouni, E. Zimlichman, T. Shochat, and I. Kochba
Autoimmune diseases in asthma.
Ann Intern Med,
June 20, 2006;
144(12):
877 - 883.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J J Corrales, M Almeida, R Burgo, M T Mories, J M Miralles, and A Orfao
Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency.
J. Endocrinol.,
June 1, 2006;
189(3):
595 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N Danchenko, J A Satia, and M S Anthony
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden
Lupus,
May 1, 2006;
15(5):
308 - 318.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. T. Page, S. R. Plymate, W. J. Bremner, A. M. Matsumoto, D. L. Hess, D. W. Lin, J. K. Amory, P. S. Nelson, and J. D. Wu
Effect of medical castration on CD4+CD25+ T cells, CD8+ T cell IFN-{gamma} expression, and NK cells: a physiological role for testosterone and/or its metabolites
Am J Physiol Endocrinol Metab,
May 1, 2006;
290(5):
E856 - E863.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Ackerman
Sex hormones and the genesis of autoimmunity.
Arch Dermatol,
March 1, 2006;
142(3):
371 - 376.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Jiang, B. A. Orr, D. M. Kranz, and D. J. Shapiro
Estrogen Induction of the Granzyme B Inhibitor, Proteinase Inhibitor 9, Protects Cells against Apoptosis Mediated by Cytotoxic T Lymphocytes and Natural Killer Cells
Endocrinology,
March 1, 2006;
147(3):
1419 - 1426.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. T. Follettie, M. Pinard, J. C. Keith Jr., L. Wang, D. Chelsky, C. Hayward, P. Kearney, P. Thibault, E. Paramithiotis, A. J. Dorner, et al.
Organ Messenger Ribonucleic Acid and Plasma Proteome Changes in the Adjuvant-Induced Arthritis Model: Responses to Disease Induction and Therapy with the Estrogen Receptor-{beta} Selective Agonist ERB-041
Endocrinology,
February 1, 2006;
147(2):
714 - 723.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. F.H. van Bommel, T. R. Hendriksz, A. W.L.C. Huiskes, and A. G.M. Zeegers
Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis
Ann Intern Med,
January 17, 2006;
144(2):
101 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Asirvatham, M. Schmidt, B. Gao, and J. Chaudhary
Androgens Regulate the Immune/Inflammatory Response and Cell Survival Pathways in Rat Ventral Prostate Epithelial Cells
Endocrinology,
January 1, 2006;
147(1):
257 - 271.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Zitzmann, M. Erren, A. Kamischke, M. Simoni, and E. Nieschlag
Endogenous Progesterone and the Exogenous Progestin Norethisterone Enanthate Are Associated with a Proinflammatory Profile in Healthy Men
J. Clin. Endocrinol. Metab.,
December 1, 2005;
90(12):
6603 - 6608.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Pudney, A. J. Quayle, and D. J. Anderson
Immunological Microenvironments in the Human Vagina and Cervix: Mediators of Cellular Immunity Are Concentrated in the Cervical Transformation Zone
Biol Reprod,
December 1, 2005;
73(6):
1253 - 1263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H. Brix, G. P. S. Knudsen, M. Kristiansen, K. O. Kyvik, K. H. Orstavik, and L. Hegedus
High Frequency of Skewed X-Chromosome Inactivation in Females with Autoimmune Thyroid Disease: A Possible Explanation for the Female Predisposition to Thyroid Autoimmunity
J. Clin. Endocrinol. Metab.,
November 1, 2005;
90(11):
5949 - 5953.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Cutolo, A Sulli, and B Seriolo
Estrogens, autoimmunity and the heart
Lupus,
September 1, 2005;
14(9):
675 - 678.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. L. Gulley, P. M. Arlen, A. Bastian, S. Morin, J. Marte, P. Beetham, K.-Y. Tsang, J. Yokokawa, J. W. Hodge, C. Menard, et al.
Combining a Recombinant Cancer Vaccine with Standard Definitive Radiotherapy in Patients with Localized Prostate Cancer
Clin. Cancer Res.,
May 1, 2005;
11(9):
3353 - 3362.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
